Different types of MDS vary in severity and are characterized by the percentage of blood progenitor cells (CD34+ blasts) in the bone marrow26, with high-risk MDS patients often progressing to acute myeloid leukemia27. The gene discussed is CD34; the disease is myelodysplastic syndrome.